Clinical Trials
4 trialsNCT04307329 2024-10-22
MIMOSA
The Netherlands Cancer Institute
Phase 2 Completed
NCT03822351 2024-10-08
COAST
MedImmune LLC
Phase 2 Completed
NCT04333914 2022-09-30
IMMUNONCOVID
Centre Leon Berard
Phase 2 Completed
NCT03794544 2022-02-24
Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer
MedImmune LLC
Phase 2 Completed